Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2004
05/13/2004US20040091890 Life sciences business systems and methods
05/13/2004US20040091889 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer
05/13/2004US20040091886 Method for generating recombinant polynucleotides
05/13/2004US20040091885 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
05/13/2004US20040091884 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders
05/13/2004US20040091883 Method for analysing and displaying ORF as well as UTR in cDNA sequences and its application to protein synthesis
05/13/2004US20040091880 Method for direct genetic analysis of target cells by using fluorescence probes
05/13/2004US20040091878 Zinc finger domain recognition code and uses thereof
05/13/2004US20040091875 Method for isolating nucleic acids
05/13/2004US20040091871 For diagnosis/treatment/prophylaxis of neuroendocrine disorders; antisense agents; kits
05/13/2004US20040091866 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
05/13/2004US20040091864 Hybridisation beacon and method of rapid sequence detection and discrimination
05/13/2004US20040091863 For inflammation/multiple sclerosis/arthritis/skin/respiratory disorders/cancer/tumors/reperfusion injuries; comprises cell-free in vitro translation system; solid phase synthesis
05/13/2004US20040091861 Novel polypeptide-human shc protein 43 and polynucleotide encoding it
05/13/2004US20040091860 Rice peroxidases with various characteristics
05/13/2004US20040091854 Polypeptides derived from rna polymerases and use thereof
05/13/2004US20040091853 Features a chimeric protein containing beta-lactamase and Vpr/Vpx region; for lentivirus/human immunodeficiency virus (HIV)
05/13/2004US20040091505 Genes encoding proteins with pesticidal activity
05/13/2004US20040091502 Circovirus sequences associated with piglet weight loss disease (PWD)
05/13/2004US20040091500 Non-naturally occurring mutants from naturally occurring allergens; overall alpha-carbon backbone tertiary structure of the allergens is preserved; use in vaccines; treating allergies; reduced immunoglobulin E (IgE) binding
05/13/2004US20040091498 Defensins: use as antiviral agents
05/13/2004US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models
05/13/2004US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
05/13/2004US20040091485 Humanised antibodies to the epidermal growth factor receptor
05/13/2004US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/13/2004US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
05/13/2004US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
05/13/2004US20040091478 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
05/13/2004US20040091472 Rationally designed polysaccharide lyases derived from chrondroitinase B
05/13/2004US20040091469 Novel enzyme having beta-glucosidase activity and use thereof
05/13/2004US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation
05/13/2004US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system
05/13/2004US20040091457 Compositions and methods for inhibiting viral replication
05/13/2004US20040091456 Novel recombinant adenovirus vector with relieved side effects
05/13/2004DE10249594A1 Immunisierung gegen Bestandteile des Humanen Immunschwächevirus (HIV) Immunization against components of the human immunodeficiency virus (HIV)
05/13/2004DE10249390A1 Rekombinante MVA-Stämme als potentielle Impfstoffe gegen P.falciparum-Malaria Recombinant MVA strains as potential vaccines against P. falciparum malaria
05/13/2004DE10223196B4 Verfahren und Einrichtung zum Transferieren von Molekülen in Zellen Method and apparatus for transferring molecules into cells
05/13/2004CA2544153A1 Method for the synthesis of a bifunctional complex
05/13/2004CA2504205A1 Angiotensin-converting enzyme containing medecine
05/13/2004CA2504142A1 Qualitative differential screening
05/13/2004CA2503890A1 Mutagenesis methods using ribavirin and/or rna replicases
05/13/2004CA2503888A1 Chimeric cytoplasmic signalling molecules
05/13/2004CA2503886A1 Recombinant protein variants
05/13/2004CA2503837A1 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm
05/13/2004CA2503697A1 Trimeric binding proteins for trimeric cytokines
05/13/2004CA2503422A1 Compositions for cancer treatment
05/13/2004CA2500863A1 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
05/13/2004CA2496016A1 Methods for increasing total oil levels in plants
05/13/2004CA2486104A1 Tri-block polymers for nanosphere-based drug or gene delivery
05/13/2004CA2485342A1 Humanized antibodies against the venezuelan equine encephalitis virus
05/13/2004CA2411729A1 Knock-in mouse prostate cancer model
05/12/2004EP1418243A2 Microfluidic system for analyzing nucleic acids
05/12/2004EP1418237A2 Anti-Kazlauskas lipases
05/12/2004EP1418236A1 Mammalian chemokines
05/12/2004EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
05/12/2004EP1418230A2 Genetically modified penicillin amidase and methods of producing it
05/12/2004EP1418185A1 Use of EDG2 receptor in an animal model of heart failure
05/12/2004EP1418183A1 Cystic fibrosis gene
05/12/2004EP1418180A2 Chimeric chains that code for proteins that induce effects directed against viruses
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
05/12/2004EP1417493A2 Competitive binding assay for identifying inhibitors of hcv polymerase
05/12/2004EP1417485A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
05/12/2004EP1417475A2 Method for isolation of independent, parallel chemical micro-reactions using a porous filter
05/12/2004EP1417474A2 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
05/12/2004EP1417353A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
05/12/2004EP1417351A2 Antisense modulation of apolipoprotein(a) expression
05/12/2004EP1417350A2 Antisense modulation of hormone-sensitive lipase expression
05/12/2004EP1417349A2 Novel molecular target for neurotoxicity
05/12/2004EP1417347A2 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
05/12/2004EP1417346A2 Method for identifying macrocyclic polyketides
05/12/2004EP1417344A1 Zinc finger domain libraries
05/12/2004EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
05/12/2004EP1417341A2 Dna sequence analysis
05/12/2004EP1417340A2 Method for the detection of a polymorphism in cpb2
05/12/2004EP1417339A2 Antisense modulation of glioma-associated oncogene-2 expression
05/12/2004EP1417338A1 Genes and snps associated with eating disorders
05/12/2004EP1417337A2 Methods and devices based upon a novel form of nucleic acid duplex on a surface
05/12/2004EP1417336A2 Exponential nucleic acid amplification using nicking endonucleases
05/12/2004EP1417335A2 Antisense modulation of glioma-associated oncogene-3 expression
05/12/2004EP1417332A2 Nucleic acid extraction method and kit
05/12/2004EP1417329A1 Methods for generating antibiotic resistant microbes and novel antibiotics
05/12/2004EP1417328A2 Invasion complex and methods of targeting
05/12/2004EP1417327A2 Multi-site mutagenesis
05/12/2004EP1417323A2 Humanised baculovirus
05/12/2004EP1417322A2 Plant glycogenin homologs and use thereof in starch modification
05/12/2004EP1417321A2 Double fructan beets
05/12/2004EP1417320A2 Transgenic plants expressing cobalamin binding proteins
05/12/2004EP1417319A2 Constitutive plant promoter
05/12/2004EP1417318A2 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof
05/12/2004EP1417317A2 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same
05/12/2004EP1417315A2 Plant ion channels and methods
05/12/2004EP1417314A2 Novel amylases and uses thereof
05/12/2004EP1417313A1 Adenosylmethionine synthetase from streptomyces sp., gene sequences coding the same and method for mass production of secondary metabolites including antibiotics thereof
05/12/2004EP1417312A2 Herbicide tolerant cotton plants and methods for producing and identifying same
05/12/2004EP1417311A2 Maize basal layer antimicrobial protein polynucleotides and methods of use
05/12/2004EP1417310A2 Nucleic acid and amino acid sequences of a vegf variant
05/12/2004EP1417309A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
05/12/2004EP1417308A1 Human protooncogene kg-20 and protein encoded therein
05/12/2004EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis
05/12/2004EP1417306A2 High-throughput dna-isolation and transfection for analysing the function of genes or genetic products